Clinical Research M&A: A Slower Year
Source: Life Science Leader
By ISR
Recent M&A activity in the clinical research space has been dominated by large deals like the mergers between Quintiles+IMS Health and INC Research+inVentiv Health. 2018 marked a departure from massive consolidation with organizations focusing on acquiring small, specialist firms to expand their service offerings.
access the Magazine Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader
This website uses cookies to ensure you get the best experience on our website. Learn more